The Newsroom
Item 1 of 3
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
Item 2 of 3
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Item 3 of 3
Mayor Demings, AdventHealth on bridging health care gaps
Recent Stories at AdventHealthMD
-
-
New treatment for AFib patients shows less tissue damage and improved outcomes, offered first at AdventHealth
-
AdventHealth Physician Team Performs Central Florida’s First Immediate Breast Neurotization After Nipple-sparing Mastectomy
-
AdventHealth for Women Launches Central Florida’s First Comprehensive Uterine Fibroid Program to Enhance Patient Care
-
AdventHealth for Children Recruiting Patients with Fabry Disease for Phase III PERIDOT Clinical Trial Evaluating a Potential New Treatment Option
-
AdventHealth Celebration is Among First in the State to Offer Non-invasive Histotripsy Treatment for Unresectable Liver Tumors
-
Harnessing Music’s Healing Power for Stroke Survivors in Central Florida
-
Chief Clinical Officer Appointed to Serve the AdventHealth East Florida Division
-
AdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome